Cargando…

Broad Spectrum Antiviral Activity of Favipiravir (T-705): Protection from Highly Lethal Inhalational Rift Valley Fever

BACKGROUND: Development of antiviral drugs that have broad-spectrum activity against a number of viral infections would be of significant benefit. Due to the evolution of resistance to currently licensed antiviral drugs, development of novel anti-influenza drugs is in progress, including Favipiravir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caroline, Amy L., Powell, Diana S., Bethel, Laura M., Oury, Tim D., Reed, Douglas S., Hartman, Amy L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983105/ https://www.ncbi.nlm.nih.gov/pubmed/24722586 http://dx.doi.org/10.1371/journal.pntd.0002790

Ejemplares similares

Inflammatory Biomarkers Associated with Lethal Rift Valley Fever Encephalitis in the Lewis Rat Model
por: Caroline, Amy L., et al.
Publicado: (2016)

Lethal Mutagenesis of Rift Valley Fever Virus Induced by Favipiravir
por: Borrego, Belén, et al.
Publicado: (2019)

Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus
por: Bales, Jacquelyn M., et al.
Publicado: (2012)

Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus
por: Tani, Hideki, et al.
Publicado: (2016)

Advances in Understanding Neuropathogenesis of Rift Valley Fever Virus
por: Connors, Kaleigh A., et al.
Publicado: (2022)

Neutrophil and macrophage influx into the central nervous system are inflammatory components of lethal Rift Valley fever encephalitis in rats
por: Albe, Joseph R., et al.
Publicado: (2019)

Lrp1 is essential for lethal Rift Valley fever hepatic disease in mice
por: Schwarz, Madeline M., et al.
Publicado: (2023)

Severe fever with thrombocytopenia syndrome (SFTS) treated with a novel antiviral medication, favipiravir (T-705)
por: Song, Rui, et al.
Publicado: (2019)

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
por: FURUTA, Yousuke, et al.
Publicado: (2017)

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
por: Furuta, Yousuke, et al.
Publicado: (2009)

Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever
por: Oestereich, Lisa, et al.
Publicado: (2014)

Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
por: Yamada, Kentaro, et al.
Publicado: (2016)

Rift Valley Fever Virus Infection Causes Acute Encephalitis in the Ferret
por: Barbeau, Dominique J., et al.
Publicado: (2020)

The Pathogenesis of Rift Valley Fever
por: Ikegami, Tetsuro, et al.
Publicado: (2011)

Rift Valley Fever Encephalitis
por: Alrajhi, Abdulrahman A., et al.
Publicado: (2004)

Rift Valley Fever in Chad
por: Ringot, David, et al.
Publicado: (2004)

Favipiravir (T-705) Protects IFNAR(−/−) Mice against Lethal Zika Virus Infection in a Sex-Dependent Manner
por: Matz, Keesha, et al.
Publicado: (2021)

Rift Valley Fever Virus Is Lethal in Different Inbred Mouse Strains Independent of Sex
por: Cartwright, Haley N., et al.
Publicado: (2020)

Development of Rift valley fever encephalitis in rats is mediated by early infection of olfactory epithelium and neuroinvasion across the cribriform plate
por: Boyles, Devin A., et al.
Publicado: (2020)

Rift Valley Fever in Goats, Cameroon
por: LeBreton, Matthew, et al.
Publicado: (2006)

RIFT VALLEY FEVER: LESSONS TO BE LEARNED
por: Alam, Awatif A., et al.
Publicado: (2000)

Rift Valley Fever in Namibia, 2010
por: Monaco, Federica, et al.
Publicado: (2013)

Rift Valley Fever Potential, Arabian Peninsula
por: Anyamba, Assaf, et al.
Publicado: (2006)

Rift Valley Fever, Sudan, 2007 and 2010
por: Aradaib, Imadeldin E., et al.
Publicado: (2013)

Congenital Rift Valley fever in Sprague Dawley rats is associated with diffuse infection and pathology of the placenta
por: McMillen, Cynthia M., et al.
Publicado: (2022)

Favipiravir (T-705) protects against Nipah virus infection in the hamster model
por: Dawes, Brian E., et al.
Publicado: (2018)

Susceptibility and barriers to infection of Colorado mosquitoes with Rift Valley fever virus
por: Hartman, Daniel A., et al.
Publicado: (2021)

A Hyper-Attenuated Variant of Rift Valley Fever Virus Generated by a Mutagenic Drug (Favipiravir) Unveils Potential Virulence Markers
por: Borrego, Belén, et al.
Publicado: (2021)

Potential Effects of Rift Valley Fever in the United States
por: Hartley, David M., et al.
Publicado: (2011)

Favipiravir (T-705) Inhibits Junín Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever
por: Gowen, Brian B., et al.
Publicado: (2013)

The 2007 Rift Valley Fever Outbreak in Sudan
por: Hassan, Osama Ahmed, et al.
Publicado: (2011)

Rift Valley Fever, Mayotte, 2007–2008
por: Sissoko, Daouda, et al.
Publicado: (2009)

Molecular Biology of Rift Valley Fever Virus
por: Bouloy, Michele, et al.
Publicado: (2010)

Molecular Epidemiology of Rift Valley Fever Virus
por: Grobbelaar, Antoinette A., et al.
Publicado: (2011)

An Assembly Model of Rift Valley Fever Virus
por: Rusu, Mirabela, et al.
Publicado: (2012)

Reemergence of Rift Valley Fever, Mauritania, 2010
por: Faye, Ousmane, et al.
Publicado: (2014)

The Risk of Nosocomial Transmission of Rift Valley Fever
por: Al-Hamdan, Nasser A., et al.
Publicado: (2015)

Sociocultural and Economic Dimensions of Rift Valley Fever
por: Muga, Geoffrey Otieno, et al.
Publicado: (2015)

Antiviral and protective effect of small interfering RNAs against rift valley fever virus in vitro
por: Ahmed, Engy. M., et al.
Publicado: (2023)

Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review
por: Srinivasan, Kritika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_203cqf72ca9i60qam7ebh4p193